Hypertonic saline solution reduces the inflammatory response in endotoxemic rats

Clinics (Sao Paulo). 2012 Dec;67(12):1463-8. doi: 10.6061/clinics/2012(12)18.

Abstract

Objective: Volume replacement in septic patients improves hemodynamic stability. This effect can reduce the inflammatory response. The objective of this study was to evaluate the effect of 7.5% hypertonic saline solution versus 0.9% normal saline solution for volume replacement during an inflammatory response in endotoxemic rats.

Methods: We measured cytokines (serum and gut), nitrite, and lipid peroxidation (TBARS) as indicators of oxidative stress in the gut. Rats were divided into four groups: control group (C) that did not receive lipopolysaccharide; lipopolysaccharide injection without treatment (LPS); lipopolysaccharide injection with saline treatment (LPS +S); and lipopolysaccharide injection with hypertonic saline treatment (LPS +H). Serum and intestine were collected. Measurements were taken at 1.5, 8, and 24 h after lipopolysaccharide administration.

Results: Of the four groups, the LPS +H group had the highest survival rate. Hypertonic saline solution treatment led to lower levels of IL-6, IL-10, nitric oxide, and thiobarbituric acid reactive substances compared to 0.9% normal saline. In addition, hypertonic saline treatment resulted in a lower mortality compared to 0.9% normal saline treatment in endotoxemic rats. Volume replacement reduced levels of inflammatory mediators in the plasma and gut.

Conclusion: Hypertonic saline treatment reduced mortality and lowered levels of inflammatory mediators in endotoxemic rats. Hypertonic saline also has the advantage of requiring less volume replacement.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Models, Animal
  • Endotoxemia / chemically induced
  • Endotoxemia / metabolism*
  • Hemodynamics / drug effects
  • Inflammation Mediators / blood
  • Inflammatory Bowel Diseases / metabolism
  • Inflammatory Bowel Diseases / pathology
  • Inflammatory Bowel Diseases / prevention & control
  • Interleukin-10 / metabolism
  • Interleukin-6 / metabolism
  • Interleukins / metabolism*
  • Lipid Peroxidation / drug effects*
  • Lipopolysaccharides / administration & dosage
  • Male
  • Nitrites / metabolism*
  • Oxidative Stress*
  • Random Allocation
  • Rats
  • Rats, Wistar
  • Saline Solution, Hypertonic / pharmacology*
  • Survival Analysis
  • Systemic Inflammatory Response Syndrome / metabolism
  • Systemic Inflammatory Response Syndrome / therapy*

Substances

  • Inflammation Mediators
  • Interleukin-6
  • Interleukins
  • Lipopolysaccharides
  • Nitrites
  • Saline Solution, Hypertonic
  • Interleukin-10